The Start of Elysium Health
Elysium Health is a health startup that was founded in 2014. It was founded by Dr. Leonard Guarente, the director of the Glenn Center for Biology of Aging Research at MIT. He has conducted significant research on the genetic and molecular causes of aging during his scientific career.
Elysium Health works together works together with world-class scientists to translate advances in science and technology into clinically-validated health products that work. The goal of the company is to help people live healthier, longer.
Eating a healthy diet is a proven way to improve your personal well-being. Eating foods that are high in essential vitamins and nutrients, as opposed to processed foods, is a great way to provide your body with the fuel it needs. Additionally, exercising is vital to living an active lifestyle. Exercising on a regular basis helps you maintain energy levels and bone density as you age, for example.
Elysium Health sells a supplement called Basis. This supplement works to increase levels of the coenzyme NAD+ in our cells. NAD+ is essential to many of our cellular functions like energy creation, circadian rhythms, and DNA protection. But as we age, our levels of NAD+ naturally decline and those functions break down. Basis is clinically proven to increase levels of NAD+ by an average of 40% in humans and is a great way to support your cellular health.
Each jar of Basis contains 60 capsules. Since the recommended daily intake of the supplement is two capsules, that means each jar has about a month’s worth of Basis. Elysium Health sells monthly subscriptions to Basis on its website starting at $50 per month. Purchasing a six-month subscription costs $270, which is more money upfront but less money on a monthly basis ($45 per month). The savings and the fact that Basis is designed for long-term use make this the most popular subscription.
Elysium Health is developing new products that focus on the microbiome, cognitive health, skin health, muscle function, and circadian rhythms. These products are in various stages of pre-clinical and clinical trials.
Targeting systems as opposed to symptoms – scientists are pushing to change the way we define #Alzheimers by the many biological changes it causes. Read more @NPR: https://t.co/SlV3B93Spd @alzdemjournals
— Elysium Health (@ElysiumHQ) April 11, 2018
For more information on Elysium Health, the company’s team of scientists, and the science behind Basis visit Elysium’s website.